Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes

Pulmonary hypertension (PH) is characterized by a resting mean pulmonary artery pressure (PAP) of 20 mmHg or more and is a disease of multiple etiologies. Of the various types of PH, pulmonary arterial hypertension (PAH) is characterized by elevated resistance in the pulmonary arterial tree. It is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckmann, Taylor, Shelley, Patrisha, Patel, Darshan, Vorla, Mounica, Kalra, Dinesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609426/
https://www.ncbi.nlm.nih.gov/pubmed/36297354
http://dx.doi.org/10.3390/ph15101242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609426/
https://www.ncbi.nlm.nih.gov/pubmed/36297354
http://dx.doi.org/10.3390/ph15101242

Ejemplares similares